Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-022219

Options or other derivatives

  • Chief Clin. Ops. Officer acquired 600,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MAIDA ANTHONY E III · Chief Clin. Ops. Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-03 Grant or award : show line 1 in the form Stock Options +600,000 600,000 D
Loading xslF345X03/ownership.xml…